Merck KGaA Bolsters Life Sciences Portfolio with $11.3B Bio-Techne Acquisition Acquisition of a medical tools maker will be the German group’s biggest in over a decade. Credit: Martin Leissl/Bloomberg Subscribe now Already have an account? Sign in.
